Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Alabama at Birmingham
About this trial
This study will evaluate the use of the Venous Excess Ultrasound (VExUS) score to guide fluid management in critically ill ICU patients through a prospective, multi-aim design combining observational and randomized components. The study will be conducted in the medical intensive care unit (MICU), multidisciplinary critical care unit (MCCU), and cardiac care unit (CCU) at UAB.
Eligibility criteria
Qualifiers
Adults (≥18 years old)
Admitted to the MICU, MCCU, or CCU within 24 hours of admission
Acute kidney injury (AKI) (based on Kidney Disease: Improving Global Outcomes (KDIGO) criteria)
Adequate acoustic windows for a complete VExUS scan
Disqualifiers
< 18 years old
pregnant women
End-stage renal disease (ESRD) or prior renal transplant
Acute tubular necrosis (ATN) defined by urinalysis (≥2+ protein, ≥2+ blood, ≥1 muddy brown cast, ≥1 RBC cast, or ≥1 dysmorphic RBC)'
Trial design
Treatments tested in this trial
- Fluid Management
- No intervention
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov